Paper39741663
Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review.
Skrobucha A and 4 others. Front Cardiovasc Med, 2024. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review. Papers, record 39741663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39741663
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35400496 | Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis. | Atherosclerosis | 2022 | https://conductscience.org/library/papers/35400496 | PubMed |
| 2 | 23868944 | Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. | Arterioscler Thromb Vasc Biol | 2013 | https://conductscience.org/library/papers/23868944 | PubMed |
| 3 | 34356845 | Inflammatory Mechanisms Contributing to Endothelial Dysfunction. | Biomedicines | 2021 | https://conductscience.org/library/papers/34356845 | PubMed |
| 4 | 19195607 | Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. | J Am Coll Cardiol | 2009 | https://conductscience.org/library/papers/19195607 | PubMed |
| 5 | 36799940 | Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies. | Eur J Prev Cardiol | 2023 | https://conductscience.org/library/papers/36799940 | PubMed |
| 6 | 37522848 | Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy. | Endocr Connect | 2023 | https://conductscience.org/library/papers/37522848 | PubMed |
| 7 | 19955250 | Chronic coronary artery disease: diagnosis and management. | Mayo Clin Proc | 2009 | https://conductscience.org/library/papers/19955250 | PubMed |
| 8 | 31446075 | New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling. | J Mol Biol | 2020 | https://conductscience.org/library/papers/31446075 | PubMed |
| 9 | 24267262 | Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe⁻/⁻ mice. | Atherosclerosis | 2013 | https://conductscience.org/library/papers/24267262 | PubMed |
| 10 | 26630143 | Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26630143 | PubMed |
| 11 | 31447282 | Inflammation in atherosclerosis: A key role for cytokines. | Cytokine | 2019 | https://conductscience.org/library/papers/31447282 | PubMed |
| 12 | 27110066 | Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control. | Mediators Inflamm | 2016 | https://conductscience.org/library/papers/27110066 | PubMed |
| 13 | 15616022 | Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. | Diabetes | 2005 | https://conductscience.org/library/papers/15616022 | PubMed |
| 14 | 20068138 | Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. | Diabetes | 2010 | https://conductscience.org/library/papers/20068138 | PubMed |
| 15 | 36317383 | Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol-related inflammatory parameters as predictors. | Coron Artery Dis | 2023 | https://conductscience.org/library/papers/36317383 | PubMed |
| 16 | 31002893 | GLP-1: Molecular mechanisms and outcomes of a complex signaling system. | Neurochem Int | 2019 | https://conductscience.org/library/papers/31002893 | PubMed |
| 17 | 30291013 | Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. | Lancet | 2018 | https://conductscience.org/library/papers/30291013 | PubMed |
| 18 | 31270216 | Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E-Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators. | J Pharmacol Exp Ther | 2019 | https://conductscience.org/library/papers/31270216 | PubMed |
| 19 | 26447224 | The physiological role of glucagon-like peptide-1 in the regulation of renal function. | Am J Physiol Renal Physiol | 2016 | https://conductscience.org/library/papers/26447224 | PubMed |
| 20 | 31185157 | Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31185157 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42923701 | The role of inflammation on coronary microvascular dysfunction and potential therapeutic targets. | Eur Heart J Open | 2026 | https://conductscience.org/library/papers/42923701 | PubMed |
| 42781074 | Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review. | Clin Interv Aging | 2026 | https://conductscience.org/library/papers/42781074 | PubMed |
| 42534427 | Beyond glycemic control: clinical cardiovascular effects of tirzepatide-a narrative review. | Ther Adv Endocrinol Metab | 2026 | https://conductscience.org/library/papers/42534427 | PubMed |
| 42105046 | Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category. | Diabetes Ther | 2026 | https://conductscience.org/library/papers/42105046 | PubMed |
| 42041268 | Glucagon-like Peptide-1 Receptor Agonist Therapy and Risk of Pulmonary and Systemic Infections in Diabetic Gastroparesis: A Propensity-Matched Cohort Study. | Adv Respir Med | 2026 | https://conductscience.org/library/papers/42041268 | PubMed |
| 41879791 | Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial. | JAMA Cardiol | 2026 | https://conductscience.org/library/papers/41879791 | PubMed |
| 41828519 | Oncometabolites and Hypoxia-Regulated Exosomes Shape HIF-Driven Macrophage Programs Across Type 2 Diabetes, Atherosclerosis, and Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828519 | PubMed |
| 41751159 | Exploratory Analysis of Circulating GLP-1, GIP, and TMAO in Relation to Coronary Artery Disease Severity in Patients with Exertional Angina. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751159 | PubMed |
| 41665655 | GLP-1 receptor agonists after ACS in diabetes: credible plaque signals, but comparators, confounding, and access will decide impact. | Acta Diabetol | 2026 | https://conductscience.org/library/papers/41665655 | PubMed |
| 41551027 | Do GLP-1 agonists affect perioperative risk in spine surgery? A systematic review and meta-analysis. | N Am Spine Soc J | 2026 | https://conductscience.org/library/papers/41551027 | PubMed |
| 41511355 | Inflammatory Mechanisms in Acute Coronary Syndromes: From Pathophysiology to Therapeutic Targets. | Cells | 2025 | https://conductscience.org/library/papers/41511355 | PubMed |
| 41482411 | Anti-inflammatory Pathways of Novel Anti-diabetic Therapies. A Literature Review. | In Vivo | 2026 | https://conductscience.org/library/papers/41482411 | PubMed |
| 41392086 | Glucagon-like peptide-1 receptor agonist in large vessel occlusion treated by reperfusion therapy-a phase 2 randomized trial. | Nat Commun | 2025 | https://conductscience.org/library/papers/41392086 | PubMed |
| 41378487 | Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction. | J Am Heart Assoc | 2025 | https://conductscience.org/library/papers/41378487 | PubMed |
| 41378166 | Precision cardiovascular medicine: shifting the innovation paradigm. | Front Sci | 2025 | https://conductscience.org/library/papers/41378166 | PubMed |
| 41301689 | Complementary Yet Distinct Roles of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Cardiovascular Risk Reduction. | Biomedicines | 2025 | https://conductscience.org/library/papers/41301689 | PubMed |
| 41286370 | The obesity-inflammation axis in psoriatic disease: mechanisms and therapeutic strategies. | Nat Rev Rheumatol | 2026 | https://conductscience.org/library/papers/41286370 | PubMed |
| 41155741 | Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 Cardiomyocytes. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41155741 | PubMed |
| 40872593 | Cardiovascular Protection in Coronary Artery Disease: Mechanistic and Clinical Insights into SGLT2 Inhibitors and GLP-1 Receptor Agonists. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40872593 | PubMed |
| 40735319 | GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation. | Front Immunol | 2025 | https://conductscience.org/library/papers/40735319 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCG | 2641 | PubTator's text mining | https://conductscience.org/library/genes/2641 | NCBI Gene |
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39741663
GET https://conductscience.org/api/papers/v1/39741663/references?page=2